Append Medical
Or Yehuda
About Append Medical
Append Medical develops a next-generation transcatheter Left Atrial Appendage (LAA) closure system. The Append Medical solution is in the pre-clinical in-vivo trial phase. It is intended to become a differentiated solution in the LAA closure market, which has been estimated to reach $25B within several years. This is the second-fastest growing segment of the medical device market, with potential sales of $500M in 2019. Append Medical is a member of MEDX Xelerator, a medtech incubator backed by Boston Scientific, Intellectual Ventures, MEDX Ventures and Sheba Medical Center.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $11.8M
- Funding stage: Early Stage Venture
- Last round: Convertible Note (Oct 2024)
- Website: appendmedical.com
- Phone: +972-547-250-960
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device, mHealth
Social Profiles
Canonical: https://fsome.com/organization/append-medical-49336 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.